Learning objectives: To report on global failures or weaknesses in vaccinating low- and middle-income countries especially in Latin America, Southeast Asia, and Africa versus pandemic threats and neglected tropical diseases.

To summarize efforts at our Texas Children’s Hospital Center for Vaccine Development to develop new recombinant protein COVID vaccines used India and Indonesia where they are known as CORBEVAX and INDOVAC, respectively. In addition to a new human hookworm vaccine.

Session date: 
04/16/2024 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Peter J. Hotez, MD, PhD